Follow the 바이넥스 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 바이넥스 has recorded 38 reports. Market capitalisation: €203.8bn. The latest transaction was disclosed on 3 July 2026 (Other). Among the most active insiders: 더에이블. Every trade is openly available.
38
Insider Decl.
n/a
Thresholds
n/a
10 ops.
Buy Volume
n/a
4 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,677 of 29,064 companies
19.9
score / 100
Value
17
Quality
23
FCF yld-20%
Earn yld-1.4%
EV/EBITDA25.8x
ROE·
Gross mgn27%
Net mgn-1.9%
Debt/EBITDA7.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
바이넥스 es una empresa de salud y farmacéutica que cotiza en el mercado XKRX. Se especializa en el desarrollo y la fabricación de productos farmacéuticos.